285 related articles for article (PubMed ID: 11455616)
21. Macrophages: a crucial reservoir for human immunodeficiency virus in the body.
Balestra E; Perno CF; Aquaro S; Panti S; Bertoli A; Piacentini M; Forbici F; D'Arrigo R; Calió R; Garaci E
J Biol Regul Homeost Agents; 2001; 15(3):272-6. PubMed ID: 11693436
[TBL] [Abstract][Full Text] [Related]
22. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS.
Williams KC; Hickey WF
Annu Rev Neurosci; 2002; 25():537-62. PubMed ID: 12052920
[TBL] [Abstract][Full Text] [Related]
23. HIV-1 expression protects macrophages and microglia from apoptotic death.
Cosenza MA; Zhao ML; Lee SC
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):478-90. PubMed ID: 15488024
[TBL] [Abstract][Full Text] [Related]
24. Cell death mechanisms in HIV-associated dementia: the involvement of syncytia.
Nardacci R; Antinori A; Kroemer G; Piacentini M
Cell Death Differ; 2005 Aug; 12 Suppl 1():855-8. PubMed ID: 15846379
[No Abstract] [Full Text] [Related]
25. Human immunodeficiency virus and the brain.
Glass JD; Johnson RT
Annu Rev Neurosci; 1996; 19():1-26. PubMed ID: 8833434
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of HIV infection of the central nervous system and pathogenesis of AIDS-dementia complex.
Dal Canto MC
Neuroimaging Clin N Am; 1997 May; 7(2):231-41. PubMed ID: 9113688
[TBL] [Abstract][Full Text] [Related]
27. Microglial activation and neurological symptoms in the SIV model of NeuroAIDS: association of MHC-II and MMP-9 expression with behavioral deficits and evoked potential changes.
Berman NE; Marcario JK; Yong C; Raghavan R; Raymond LA; Joag SV; Narayan O; Cheney PD
Neurobiol Dis; 1999 Dec; 6(6):486-98. PubMed ID: 10600404
[TBL] [Abstract][Full Text] [Related]
28. Microglia in human disease, with an emphasis on acquired immune deficiency syndrome.
Dickson DW; Mattiace LA; Kure K; Hutchins K; Lyman WD; Brosnan CF
Lab Invest; 1991 Feb; 64(2):135-56. PubMed ID: 1997729
[TBL] [Abstract][Full Text] [Related]
29. Murine models for human immunodeficiency virus type 1-associated dementia: the development of new treatment testing paradigms.
Persidsky Y; Gendelman HE
J Neurovirol; 2002 Dec; 8 Suppl 2():49-52. PubMed ID: 12491151
[TBL] [Abstract][Full Text] [Related]
30. IL-16 expression in lymphocytes and microglia in HIV-1 encephalitis.
Zhao ML; Si Q; Lee SC
Neuropathol Appl Neurobiol; 2004 Jun; 30(3):233-42. PubMed ID: 15175077
[TBL] [Abstract][Full Text] [Related]
31. Neurobiology of HIV.
Hult B; Chana G; Masliah E; Everall I
Int Rev Psychiatry; 2008 Feb; 20(1):3-13. PubMed ID: 18240058
[TBL] [Abstract][Full Text] [Related]
32. Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy.
Tyor WR; Wesselingh SL; Griffin JW; McArthur JC; Griffin DE
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(4):379-88. PubMed ID: 7600105
[TBL] [Abstract][Full Text] [Related]
33. Evolving paradigms in the pathogenesis of HIV-1-associated dementia.
Fischer-Smith T; Rappaport J
Expert Rev Mol Med; 2005 Dec; 7(27):1-26. PubMed ID: 16321172
[TBL] [Abstract][Full Text] [Related]
34. Regulation of CC chemokine receptor 5 and CD4 expression and human immunodeficiency virus type 1 replication in human macrophages and microglia by T helper type 2 cytokines.
Wang J; Crawford K; Yuan M; Wang H; Gorry PR; Gabuzda D
J Infect Dis; 2002 Apr; 185(7):885-97. PubMed ID: 11920312
[TBL] [Abstract][Full Text] [Related]
35. Astrocyte differentiation selectively upregulates CCL2/monocyte chemoattractant protein-1 in cultured human brain-derived progenitor cells.
Lawrence DM; Seth P; Durham L; Diaz F; Boursiquot R; Ransohoff RM; Major EO
Glia; 2006 Jan; 53(1):81-91. PubMed ID: 16206198
[TBL] [Abstract][Full Text] [Related]
36. Characterization of cultured microglia that can be infected by HIV-1.
Albright AV; Shieh JT; O'Connor MJ; González-Scarano F
J Neurovirol; 2000 May; 6 Suppl 1():S53-60. PubMed ID: 10871766
[TBL] [Abstract][Full Text] [Related]
37. [HIV encephalopathy--clinical aspects, neuropathology and pathogenesis].
Schielke E
Nervenarzt; 1993 Feb; 64(2):83-90. PubMed ID: 8450899
[TBL] [Abstract][Full Text] [Related]
38. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases.
Yoshioka M; Bradley WG; Shapshak P; Nagano I; Stewart RV; Xin KQ; Srivastava AK; Nakamura S
Adv Neuroimmunol; 1995; 5(3):335-58. PubMed ID: 8748077
[TBL] [Abstract][Full Text] [Related]
39. Macrophages, chemokines and neuronal injury in HIV-1-associated dementia.
Ryan LA; Cotter RL; Zink WE; Gendelman HE; Zheng J
Cell Mol Biol (Noisy-le-grand); 2002 Mar; 48(2):137-50. PubMed ID: 11995633
[TBL] [Abstract][Full Text] [Related]
40. Is repetitive opportunistic infection in AIDS patients the effective mechanism for neurodegeneration in terms of endlessly amplifying cytokine/chemokine effect?
Agius LM
Med Hypotheses; 2004; 62(4):587-92. PubMed ID: 15050112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
